ArticleEuroasian journal of hepato-gastroenterology
Impact of Clinical Outcomes and Prognostic Nutritional Index in Patients with Advanced Pancreatic Cancer Treated at a Tertiary Care Hospital in Pakistan.
Article in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim and background: The prognosis of advanced pancreatic cancer is also found to be associated with the host's nutritional status. The prognostic nutritional index (PNI) is an emerging marker that uses serum albumin and lymphocyte count, found to be a potent prognostic measure in many malignancies. However, its efficacy in predicting clinical outcomes in pancreatic cancer is not well explored in low- and middle-income countries (LMICs), like Pakistan. Objective: To evaluate the association between PNI and clinical outcomes in patients with advanced pancreatic cancer treated at a tertiary care hospital in Pakistan between 2019 and 2023. Materials and methods: A retrospective study was conducted using patient's record who were diagnosed with locally advanced or metastatic pancreatic cancer from Aga Khan University Hospital (AKUH). Prognostic nutritional index was calculated at diagnosis and at 12 months or last follow-up. The primary outcome was to assess the association between PNI and progression-free survival (PFS). The secondary outcome was to assess the association between PNI and type of chemotherapy drug, weight, age, stage, smoking, and alcohol intake, family history, and albumin levels at different intervals. Results: Among the included 47 patients, the association between PNI and survival was 19 months (6.44 months). Multivariable analysis showed albumin at 12 months was correlated with PNI. While the multivariable analysis of factors affecting survival revealed following significant factors, eastern cooperative oncology group (ECOG) performance, weight changes, frequency of nutritional assessment done and response evaluation. Conclusion: The PNI association with PFS further concretes the importance of this tool in clinical practices. This can lead to early identification of malnourished patients who can be treated with prompt nutritional interventions to treat pancreatic cancer-related cachexia. This is more important in context of LMIC like Pakistan where such worse outcomes add more burden on an already weak health infrastructure. However, more prospective studies with larger samples are needed to explore this associations and factors affecting PNI in more detail. Clinical significance: This study highlights the importance of nutritional assessment by utilizing PNI in patients with advanced pancreatic cancer. How to cite this article: Ahmed F, Amjad A, Saleem W,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.